UK pharmaceutical companies aim to put executive pay on par with US rivals’ but package will depend on share price

• Business live – latest updates

The pay of GSK’s chief executive could rise to nearly £22m in the next three years as the pharmaceutical company attempts to offer US-style pay packets to top executives.

Emma Walmsley’s package could increase to a maximum of £21.56m if the company’s share price rises by at least 50% and it hits stretching targets, according to its annual report.